heart attack

A new study suggests that people who discontinue GLP-1 medications, such as Ozempic and Wegovy, may face an increased risk of heart attack and stroke. The findings add to ongoing debate about how long patients should stay on these widely used weight-loss and diabetes drugs, and whether the cardiovascular benefits persist after stopping treatment.

Scientists report identifying a previously unknown brain circuit that could explain why heart attacks often worsen after the initial event. The finding suggests the brain may trigger processes that compound damage to the heart in the hours and days following an attack. If confirmed, the discovery could open new avenues for treating patients after a heart attack and reducing long-term harm.